is ozempic a tirzepatide or semaglutide vs Mounjaro: Comparing GLP‑1 Injectable Weight‑Loss Meds, vs Tirzepatide, and Real Side Effects Tirzepatide versus Semaglutide Weight Loss

LIV Body does not prescribe medication - prescribing decisions are made independently by licensed providers through OpenLoop Healthcare Partners, PC

Wegovy is also approved to reduce the risk of serious cardiovascular events, such as heart attack and stroke, in adults with cardiovascular disease and obesity or overweight

After 20 weeks of treatment, improvements in LM and SMM were observed across all groups except those receiving the lowest dose (52.5 mg)

As you can see, the average weight loss is 7.59 pounds in the first month, 12.86 pounds over the first two months, 18.23 pounds over the first three months, 23.49 pounds over the first four months, 27.27 pounds over the first five months, 32.83 pounds over the first six months, 38.49 pounds over the first seven months and then 40.92 pounds over the first eight months

It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)